Evidence map›Paper›PMID 28493226›Full record

SynthesisSchmerz (Berlin, Germany)2017

[Etiology and pathophysiology of fibromyalgia syndrome : Updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups].

N Üçeyler, M Burgmer, E Friedel, W Greiner, F Petzke, M Sarholz, M Schiltenwolf, A Winkelmann, C Sommer, W Häuser

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Schmerz (Berlin, Germany), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Mirtazapine for fibromyalgia in adults.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Pooled it
  4. Patient Version of Guideline for Fibromyalgia (2025 Edition).Journal of evidence-based medicine · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Post-COVID Patients With New-Onset Chronic Pain 2 Years After Infection: Cross-Sectional Study.Pain management nursing : official journal of the American Society of Pain Management Nurses · 2023
    Article
  11. Article
  12. Article
  13. Methylation factors as biomarkers of fibromyalgia.Annals of translational medicine · 2023
    Article
  14. Fibromyalgia, Pain, and Physical Activity: A Bibliometric Analysis.International journal of environmental research and public health · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Facts and myths pertaining to fibromyalgia.Dialogues in clinical neuroscience · 2018
    Review
  20. [Stress-induced hyperalgesia].Schmerz (Berlin, Germany) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

N ÜçeylerNeurologische Klinik, Universitätsklinikum Würzburg, Würzburg, Deutschland. ueceyler_n@ukw.de.
M BurgmerKlinik für Psychosomatik und Psychotherapie, Universitätsklinikum Münster, Münster, Deutschland.
E FriedelMedis Research GmbH, Bad Kissingen, Deutschland.
W GreinerPsychosomatische und Psychoonkologische Tagesklinik, Universitätsklinikum Jena, Jena, Deutschland.
F PetzkeSchmerzmedizin, Klinik für Anästhesiologie, Universitätsmedizin Göttingen, Göttingen, Deutschland.
M SarholzRheumazentrum Ruhrgebiet, Herne, Deutschland.
M SchiltenwolfSektion konservative Orthopädie, Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
A WinkelmannKlinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation, Klinikum der Universität München, München, Deutschland.
C SommerNeurologische Klinik, Universitätsklinikum Würzburg, Würzburg, Deutschland.
W HäuserInnere Medizin I, Klinikum Saarbrücken gGmbH, Saarbrücken, Deutschland.
Universitätsklinikum Würzburg · DEJena University Hospital · DEKlinikum Saarbrücken · DEKlinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation · DELaboklin (Germany) · DERheumazentrum Ruhrgebiet · DEUniversitätsmedizin Göttingen · DEUniversity Hospital Heidelberg · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was planned for April 2017.

methodsThe guidelines were developed by 13 scientific societies and 2 patient self-help organizations coordinated by the German Pain Society. Working groups (n =8) with a total of 42 members were formed balanced with respect to gender, medical expertise, position in the medical or scientific hierarchy and potential conflicts of interest. A systematic search of the literature from December 2010 to May 2016 was performed in the Cochrane library, MEDLINE, PsycINFO and Scopus databases. Prospective population-based studies and systematic reviews with meta-analyses of case control studies were taken into consideration for the statements. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine version 2009. The statements were generated by multiple step formalized procedures. The guidelines were reviewed and approved by the board of directors of the societies engaged in the development of the guidelines.

resultsCurrent data do not enable identification of distinct factors in the etiology and pathophysiology of fibromyalgia syndrome. Fibromyalgia syndrome can be associated with inflammatory rheumatic diseases, gene polymorphisms, life style factors (e.g. smoking, obesity and lack of physical activity), depressive disorders as well as physical and sexual abuse in childhood and adulthood.

conclusionFibromyalgia syndrome is most probably the end result of various pathogenetic factors and pathophysiological mechanisms.

Indexed as

Practice Guidelines as TopicCase-Control StudiesConsensus Statements as TopicEvidence-Based MedicineFibromyalgiaGermanyHumansSmall Fiber NeuropathySocieties, MedicalFibromyalgia syndromeGuidelinesPathophysiologyReview, systematicSmall fiber pathology

Identifiers

PMID28493226
OpenAlexW2613766323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.